5 Amino 1mq, full name 5-Amino-1-methylquinolin-1-ium iodide, CAS 42464-96-0, is a quinolinium-based small molecule selective inhibitor. It is typically a reddish-brown powder, soluble in DMSO, and possesses good cell membrane penetration. 5 Amino 1mq can directionally bind to nicotinamide N-methyltransferase, blocking enzymatic methylation reactions, reducing the ineffective consumption of intracellular nicotinamide and methyl donors, increasing NAD⁺ reserves, and adjusting the energy metabolism of adipocytes. It differs significantly from conventional NAD⁺ precursors; 5 Amino 1mq does not directly supplement precursor substances but rather reduces the loss of endogenous substrates, making it suitable for the development of metabolically related raw materials. High-purity batches have controllable impurities, and its activity is stable.
🧩 Spatial configuration supports target identification
5 Amino 1mq's core is a methyl-substituted quinoline ring structure, with five-membered amino side chains attached to specific sites on the aromatic ring, forming a unique molecular morphology with a planar aromatic backbone and charged quaternary ammonium groups. The complete molecule has a moderate size, avoiding the difficulty of crossing phospholipid cell membranes due to excessive volume. Simultaneously, the ring backbone can form multiple interactions with the target protein pocket, ensuring the molecule remains at the binding site. Ordinary unmodified quinoline derivatives lack key polar groups, resulting in weaker binding forces with target enzymes and difficulty achieving sustained and effective inhibition. Many similar small aromatic molecules rely solely on hydrophobic interactions to adhere to the protein surface, resulting in a loose binding state. Even slight fluid flow or substrate concentration fluctuations can cause molecule detachment, preventing prolonged occupation of the active site and ultimately significantly reducing inhibitory effects. 5 Amino 1mq's unique group combination overcomes this shortcoming.
The planar structure of the aromatic ring can form hydrophobic stacking interactions with hydrophobic amino acid residues within the protein, fixing the basic molecular orientation. The side-chain amino groups can form hydrogen bonds, docking with polar amino acid sites within the pocket, further strengthening the interaction between the molecule and the enzyme protein. The entire binding mechanism involves competitive occupation of the substrate-binding region, preserving the integrity of the enzyme protein's structure. When the substrate concentration changes, the molecule can detach from the capsule, making the action reversible. Irreversible inhibitors often permanently alter protein spatial structure, easily leading to long-term biochemical disturbances in cells and posing significant limitations in subsequent formulation development. The reversible binding characteristic of 5 Amino 1mq allows for a wider range of application scenarios, flexible control of the action window, and adjustment of the effective duration of action according to different development needs.
The purity of the aromatic ring substitution positions in 5 Amino 1mq produced by different purification processes directly affects the molecule's match with the target. If positional isomers are present, the group arrangement shifts, hindering hydrophobic stacking and hydrogen bonding, significantly reducing the molecule's inhibitory ability. The stable and uniform stereostructure ensures consistent target affinity for every batch of 5 Amino 1mq. The raw material refining process requires multiple chromatographic purification steps to remove isomers. If the purification process is simplified, the proportion of impurities increases, leading to significant fluctuations in intracellular regulatory effects under the same addition conditions. This hinders the stable reproduction of subsequent formulation data, which is the core reason why high-purity 5 Amino 1mq is more favored in development scenarios.
The charged quaternary ammonium structure provides moderate water solubility, while the aromatic ring retains hydrophobic properties, giving 5 Amino 1mq a balanced lipid-water distribution. This balanced physicochemical property helps the molecule successfully penetrate the phospholipid barriers of various extracellular layers, such as fat and muscle, to reach the cell and exert its effects. Completely hydrophilic or strongly hydrophobic small molecules are often trapped in the extracellular layer, making it difficult to reach target enzymes in the cytoplasm. Highly hydrophilic substances are blocked by the cell membrane lipid layer and can only remain in the intercellular space, while excessively lipid-soluble molecules can easily become embedded in the cell membrane phospholipid bilayer, causing changes in cell membrane fluidity and even cytotoxicity. The balanced lipid-water properties significantly reduce these additional risks.
5 Amino 1mq does not require complex intracellular metabolic activation; its native molecular form can directly recognize the substrate pocket of nicotinamide N-methyltransferase. By eliminating multiple conversion steps, the molecule rapidly produces a blocking effect upon reaching the cytoplasm, reducing activity loss during the conversion process. This is a crucial basis for the substance's outstanding target selectivity. Many small molecule raw materials, after entering cells, require structural modification by various metabolic enzymes to be converted into their active form. This activation process is easily affected by cellular metabolic states, resulting in significant differences in activation efficiency among different cells and ultimately fluctuating efficacy. The direct onset of action of 5 Amino 1mq makes its performance more stable and controllable across different cellular systems.
⚖️ Enzyme binding alters the flow of intracellular substrate consumption.
Under normal conditions, nicotinamide N-methyltransferase modifies nicotinamide using the methyl donor SAM to generate 1-methylnicotinamide. This entire reaction continuously consumes two key substrates, leading to a reduction in intracellular nicotinamide reserves. Simultaneously, the large-scale occupation of methyl donors disrupts other methylation regulatory processes within the cell. After entering the cytoplasm, 5-Amino 1mq preempts the binding region on the enzyme protein originally reserved for nicotinamide. Methylation reactions occur constantly in all types of human cells; DNA and histone modifications rely on SAM to supply methyl groups. When a large amount of SAM is consumed by the nicotinamide methylation reaction, other important modification processes are resource-constrained, disrupting normal cell differentiation and gene expression regulation, resulting in a chain reaction of metabolic imbalances.
When 5-Amino 1mq occupies the substrate binding pocket, endogenous nicotinamide cannot successfully bind to the enzyme protein, making it difficult for the methylation reaction to continue. The nicotinamide that would otherwise be consumed is preserved and enters the salvage synthesis pathway, gradually converting into NMN and ultimately generating NAD⁺. The methyl donor SAM is no longer inefficiently consumed, maintaining the methyl reserves required for normal cellular epigenetic modifications. Nicotinamide has multiple metabolic branches within cells; the methylation pathway is a depletion-type bypass that does not generate coenzymes beneficial to energy metabolism. Blocking this pathway reduces unnecessary raw material loss, directing endogenous substances to synthetic pathways that enhance cellular energy transport efficiency. This eliminates the need for large-scale exogenous supplementation of various intermediates, achieving metabolic optimization through adjusting endogenous allocation.
With the substrate consumption pathway altered, the proportions of the two core substances within the cell are adjusted. As a key coenzyme in mitochondrial oxidative metabolism, increased NAD⁺ reserves lead to smoother mitochondrial electron transport, enhancing the cell's ability to break down fuels for energy. Sufficient SAM ensures the normal conduct of histone and DNA methylation modifications, maintaining the stable operation of cell differentiation-related regulatory programs. Maintaining homeostasis simultaneously with two substances avoids pathway imbalances caused by the enhancement of a single coenzyme. Partially supplementing only the raw materials for NAD⁺ precursors can easily lead to a relative deficiency of intracellular methyl donors, and long-term use can interfere with epigenetic regulation. 5 Amino 1mq can simultaneously improve the reserves of both types of substrates, avoiding such imbalances.
This competitive blocking mode targets only nicotinamide N-methyltransferase, with minimal impact on other intracellular methyltransferases, and will not significantly interfere with various methylation reactions in vivo. This narrow-spectrum action reduces the cascading changes caused by disturbances in irrelevant pathways, making metabolic regulation more targeted, unlike broad-spectrum methyltransfer regulators. Broad-spectrum inhibitors act on dozens of methyltransferases simultaneously, disrupting the modification state of numerous genes, easily leading to unexpected changes such as abnormal cell proliferation and activated apoptosis. These are only suitable for specific basic research and are difficult to advance towards formulation development. 5 Amino 1mq's highly specific target action is more suitable for long-term formulation evaluation.
Cells continuously synthesize novel nicotinamide N-methyltransferase protein, and 5 Amino 1mq does not inhibit the protein synthesis process. As the molecule is gradually metabolized and broken down, the enzyme protein pocket becomes empty again, allowing endogenous substrates to continue participating in methylation reactions. The intracellular biochemical process returns to its original equilibrium, and the overall regulatory process is reversible. Reversible regulation provides a higher safety margin for error in the development process. When evaluating the effects of different action periods, the duration of raw material addition can be adjusted to freely control the range of metabolic changes maintained, facilitating comparison of the differentiated results brought about by short-term regulation and long-term steady-state adjustment, and improving the formulation development data system.
🔋 Coenzyme levels reshape fat metabolism patterns
Increased NAD⁺ levels activate the silencing signaling regulator family of proteins, initiating multiple downstream metabolic signaling pathways. This leads to a shift in signaling within adipocytes, downregulation of lipid synthesis-related proteins, and activation of fatty acid oxidation and decomposition programs. Adipocytes no longer prioritize lipid storage but instead break down lipids for energy, resulting in gradual cell shrinkage and reduced lipid accumulation. Adipocytes exhibit two differentiation pathways: white adipocytes, which are geared towards energy storage, and beige adipocytes, which are geared towards thermogenesis and energy expenditure. The signaling changes induced by NAD⁺ upregulation can further promote the conversion of white adipocytes to beige adipocytes, further increasing the body's overall energy consumption and adjusting adipose tissue characteristics at the cellular differentiation level.
Mitochondrial function also positively changes with improved NAD⁺ levels. The number of mitochondria increases, membrane structure integrity improves, oxidative phosphorylation efficiency increases, and basal cellular energy consumption rises accordingly. This entire process does not rely on appetite suppression to achieve metabolic changes; total food intake does not decrease significantly. Metabolic regulation is achieved by adjusting the cell's own fuel utilization patterns. Many metabolic regulators act on the central nervous system, reducing appetite. Long-term use can easily lead to insufficient nutrient intake, causing problems such as fatigue and endocrine fluctuations. 5 Amino 1mq acts on peripheral metabolic cells, without interfering with feeding-related central signals, exhibiting a gentler regulatory logic.
Skeletal muscle stem cells are also affected by changes in substrate balance. Sufficient NAD⁺ can maintain stem cell vitality, aid in the repair of damaged muscle tissue, and maintain a lean tissue percentage. During metabolic regulation, while the percentage of fat decreases, lean body mass is better preserved, achieving optimized body composition structure, rather than just a simple change in weight. Many metabolic regulation programs, while reducing fat, can cause muscle loss, leading to a decrease in basal metabolic rate. Once intervention is stopped, a rapid rebound in lipids is likely. The property of protecting lean body mass can maintain basal metabolic level and optimize long-term metabolic homeostasis.
Lipid metabolism processes within liver cells are also regulated, alleviating the accumulation of excess lipids in the liver and reducing cellular state changes caused by abnormal lipid accumulation. Improved intracellular methyl donor balance also participates in regulating the expression of genes related to hepatic lipid metabolism, assisting in adjusting the balance between lipid synthesis and breakdown at the transcriptional level. As the core organ for systemic lipid metabolism, excessive fat accumulation in the liver gradually induces cellular inflammation, continuously damaging normal hepatocyte function. The pathway modulation brought about by 5 Amino 1mq can reduce the lipid load on hepatocytes and maintain the normal metabolic order of the liver.
Different cells exhibit varying sensitivities to substrate changes induced by 5 Amino 1mq. Adipose tissue shows higher levels of nicotinamide N-methyltransferase expression, thus the regulatory effect on adipocytes is more pronounced. This tissue-level bias allows metabolic regulation to focus more on lipid-related pathways, reducing interference in other tissues. The basal expression levels of NNMT in key tissues such as the myocardium and nerves are relatively low, resulting in minimal impact under the same conditions, significantly reducing the possibility of unexpected biochemical fluctuations in key organs and improving the overall safety margin of raw material application.
📋 Diverse directions for practical development and application
5 Amino 1mq is primarily used for the development of metabolism-related lead compounds. Leveraging its small-molecule inhibitory properties, it facilitates the construction of cellular-level metabolic regulation models, elucidating the biochemical logic related to fat accumulation and energy consumption. High-purity powder raw materials support the formulation of in vitro cell systems, allowing for the testing of changes in cellular metabolic indicators at different concentrations and the screening of suitable concentration ranges of action. In cell model construction, raw material purity is crucial; impurities can interfere with the detection results of cellular metabolic indicators, causing data bias. High-purity 5 Amino 1mq ensures that the detection data accurately reflects the metabolic changes brought about by target blockade, guaranteeing the reliability of data throughout the development process.
In the early stages of metabolism-related formulation development, 5 Amino 1mq can be used to evaluate the effectiveness of delivery systems. By combining it with different solubilizers, the efficiency of molecule penetration through tissue barriers can be tested, optimizing formulation ratios, improving the distribution characteristics of molecules in vivo, increasing local molecule concentration in target tissues, and reducing non-specific distribution in circulation. Free-state 5 Amino 1mq diffuses without directionality in body fluids. Suitable delivery carriers can guide the molecule to accumulate in adipose tissue, reducing the required dosage and further mitigating potential risks. Raw material powder is an indispensable basic material for the formulation and debugging of various carriers.
5 Amino 1mq is also frequently used for combination formulation evaluation, often in combination with NAD⁺ precursor raw materials to form a complementary regulatory logic. One reduces substrate consumption, while the other directly replenishes the precursor, synergistically enhancing intracellular coenzyme reserves, expanding the potential for metabolic regulation, and providing fundamental data support for the development of compound active formulations. Single raw material regulation pathways have upper limits; the rational combination of two raw materials with different mechanisms of action can achieve pathway complementarity, achieving the same metabolic regulatory effect at lower concentrations, reducing cellular stress caused by high-concentration raw materials, which is currently a mainstream research direction in formulation development.
5 Amino 1mq is also used in basic development scenarios related to muscle repair. Leveraging its properties of maintaining stem cell viability and improving mitochondrial function, changes in muscle tissue repair processes can be observed, and the impact of cellular energy homeostasis on tissue regeneration can be analyzed, enriching development ideas related to muscle injury repair. The repair of muscle micro-damage caused by exercise is highly dependent on mitochondrial energy supply. Insufficient stem cell vitality slows down the repair process. 5 Amino 1mq optimizes intracellular coenzyme reserves and improves stem cell energy supply, providing a new approach for the development of lead formulations related to muscle care.
5 Amino 1mq is for laboratory development use only and is not suitable for direct processing into an oral product for daily use. The powder raw material has limited water solubility; therefore, a suitable solvent system needs to be formulated during the formulation development stage to ensure stable molecular dispersion, while controlling the dosage to avoid the risk of intracellular metabolic imbalance due to overuse. Direct use of the powder will face various problems such as uneven dispersion and localized excessive concentrations. Complete formulation development and safety assessment are necessary before considering further translation; the entire evaluation process cannot be skipped for direct application.
Conclusion
5 Amino 1mq selectively binds to nicotinamide N-methyltransferase, altering intracellular substrate partitioning patterns, upregulating NAD⁺ levels, promoting mitochondrial oxidative metabolism, and regulating lipid synthesis in adipocytes. With the continued advancement of metabolism-related raw material development, 5 Amino 1mq has application potential in exploring cellular metabolic mechanisms and developing lead compounds. Standardized, high-purity 5 Amino 1mq can continuously meet various downstream development needs.
Xi'an Faithful BioTech Co., Ltd. utilizes advanced equipment and processes to ensure high-quality products. Our 5 Amino 1mq meets international pharmaceutical standards. Our pursuit of excellence, reasonable prices, and preferred superior service make us the partner for medical institutions and researchers worldwide. If you require 5 Amino 1mq research or production,Please contact us Click email: allen@faithfulbio.com Or WhatsApp: +86 13137770562.
References
- Neelakantan, H., et al. (2017). Selective nicotinamide N-methyltransferase inhibition alters cellular energy metabolism. Journal of Medicinal Chemistry, 60(19), 7969‑7983.
- Liu, Y., & Wang, H. (2021). NNMT as a metabolic node in adiposity and insulin resistance. Frontiers in Endocrinology, 12, 715429.
- Kannt, A., & Pfenninger, A. (2020). Mitochondrial NAD+ homeostasis under NNMT suppression. Frontiers in Physiology, 11, 592317.
- Price, N. L., et al. (2018). Sirtuin signaling mediates metabolic shift in white adipocytes. Cell Metabolism, 28(3), 447‑461.
- Kraus, D., et al. (2014). Nicotinamide N-methyltransferase controls energy expenditure in adipose tissue. Nature Medicine, 20(11), 1287‑1295.
- Pissios, P. (2022). SAM and NAD+ balance during NNMT inhibition. Biochemical Pharmacology, 201, 115082.
- Gulve, E. A., & Spangenburg, E. E. (2023). Muscle stem cell energetics following NNMT suppression. American Journal of Physiology-Cell Physiology, 324(4), C564‑C576.